Truist Financial’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$812K Sell
5,411
-25
-0.5% -$2.72K ﹤0.01% 1900
2026
Q1
$502K Sell
5,436
-12,504
-70% -$1.26M ﹤0.01% 2081
2025
Q4
$1.83M Buy
17,940
+8,831
+97% +$790K ﹤0.01% 1346
2025
Q3
$569K Sell
9,109
-397
-4% -$21.6K ﹤0.01% 1952
2025
Q2
$495K Sell
9,506
-591
-6% -$26.4K ﹤0.01% 1975
2025
Q1
$430K Buy
+10,097
New +$436K ﹤0.01% 1950
2024
Q3
Sell
-8,073
Closed -$233K 2588
2024
Q2
$233K Buy
+8,073
New +$188K ﹤0.01% 2421
2024
Q1
Sell
-9,554
Closed -$258K 2657
2023
Q4
$258K Buy
+9,554
New +$251K ﹤0.01% 2395
2023
Q1
Sell
-13,561
Closed -$369K 2612
2022
Q4
$369K Sell
13,561
-1,716
-11% -$78.5K ﹤0.01% 2155
2022
Q3
$823K Buy
15,277
+8,251
+117% +$424K ﹤0.01% 1579
2022
Q2
$284K Buy
7,026
+3,162
+82% +$157K ﹤0.01% 2250
2022
Q1
$255K Sell
3,864
-3,197
-45% -$219K ﹤0.01% 2411
2021
Q4
$707K Sell
7,061
-5,543
-44% -$573K ﹤0.01% 1832
2021
Q3
$1.58M Sell
12,604
-2,045
-14% -$243K ﹤0.01% 1388
2021
Q2
$1.82M Sell
14,649
-6,093
-29% -$820K ﹤0.01% 1346
2021
Q1
$3.17M Buy
20,742
+2,250
+12% +$340K 0.01% 1023
2020
Q4
$2.38M Buy
18,492
+1,278
+7% +$147K ﹤0.01% 1095
2020
Q3
$1.93M Buy
17,214
+3,209
+23% +$294K ﹤0.01% 1076
2020
Q2
$1.14M Buy
14,005
+4,091
+41% +$330K ﹤0.01% 1251
2020
Q1
$690K Buy
9,914
+2,537
+34% +$195K ﹤0.01% 1415
2019
Q4
$576K Buy
+7,377
New +$532K ﹤0.01% 1758

Other funds holding GH

Truist Financial's GH Position: Q2 2026 in Review

Truist Financial reduced its Guardant Health (GH) stake by 0.46% in Q2 2026, selling an estimated $2.72K and leaving 5,411 shares worth $812K. The position accounts for ﹤0.01% of the portfolio, ranked #1900.

Truist Financial first reported a position in GH in Q4 2019 and has held it in 21 quarters since. The position peaked at $3.17M in Q1 2021. 242 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Truist Financial held 5,411 shares of Guardant Health worth $812K as of Q2 2026.
  • Truist Financial sold 25 Guardant Health shares in Q2 2026, an estimated $2.72K.
  • Guardant Health made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #1900 holding.
  • Truist Financial first reported a position in Guardant Health in Q4 2019 and has held it in 21 quarters since.
  • Truist Financial's Guardant Health position peaked at $3.17M in Q1 2021.
  • 242 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.